Net Income Summary of ChemoMetec A/S

ChemoMetec A/S's latest annual net income in 2024 was 136.28 Million DKK , down -23.72% from previous year.
ChemoMetec A/S's latest quarterly net income in 2024 FY was 136.28 Million DKK , down -23.72% from previous quarter.
ChemoMetec A/S reported an annual net income of 178.66 Million DKK in 2023, up 12.04% from previous year.
ChemoMetec A/S reported an annual net income of 159.46 Million DKK in 2022, up 80.49% from previous year.
ChemoMetec A/S reported a quarterly net income of 136.28 Million DKK for 2024 FY, down -23.72% from previous quarter.
ChemoMetec A/S reported a quarterly net income of 35.27 Million DKK for 2024 Q1, down -51.83% from previous quarter.

Annual Net Income Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Net Income of ChemoMetec A/S (2024 - 2004)

Year	Net Income	Net Income Growth
2024	136.28 Million DKK	-23.72%
2023	178.66 Million DKK	12.04%
2022	159.46 Million DKK	80.49%
2021	88.35 Million DKK	49.34%
2020	59.16 Million DKK	41.39%
2019	41.84 Million DKK	129.73%
2018	18.21 Million DKK	143.32%
2017	7.48 Million DKK	-28.59%
2016	10.48 Million DKK	31.89%
2015	7.94 Million DKK	591.13%
2014	1.15 Million DKK	232.37%
2013	346 Thousand DKK	103.51%
2012	-9.86 Million DKK	-9237.04%
2011	108 Thousand DKK	102.93%
2010	-3.68 Million DKK	-180.19%
2009	4.59 Million DKK	-65.25%
2008	13.23 Million DKK	1469.4%
2007	843 Thousand DKK	-79.41%
2006	4.09 Million DKK	273.84%
2005	-2.35 Million DKK	76.49%
2004	-10.01 Million DKK	0.0%

Year	Net Income	Net Income Growth
2024 Q4	32.86 Million DKK	0.0%
2024 FY	136.28 Million DKK	-23.72%
2024 Q1	35.27 Million DKK	-51.83%
2024 Q2	35.27 Million DKK	0.0%
2024 Q3	32.86 Million DKK	-6.84%
2023 FY	178.66 Million DKK	12.04%
2023 Q4	73.24 Million DKK	100.0%
2023 Q3	36.62 Million DKK	-65.26%
2023 Q2	105.42 Million DKK	100.0%
2023 Q1	52.71 Million DKK	-29.04%
2022 FY	159.46 Million DKK	80.49%
2022 Q1	42.59 Million DKK	-7.56%
2022 Q2	85.18 Million DKK	100.0%
2022 Q3	37.14 Million DKK	-56.4%
2022 Q4	74.28 Million DKK	100.0%
2021 FY	88.35 Million DKK	49.34%
2021 Q4	46.07 Million DKK	100.0%
2021 Q3	23.03 Million DKK	-45.51%
2021 Q2	42.27 Million DKK	100.0%
2021 Q1	21.13 Million DKK	-33.33%
2020 Q2	27.45 Million DKK	100.0%
2020 Q1	13.72 Million DKK	-33.13%
2020 Q4	31.7 Million DKK	100.0%
2020 Q3	15.85 Million DKK	-42.25%
2020 FY	59.16 Million DKK	41.39%
2019 Q4	20.52 Million DKK	100.0%
2019 Q2	10.65 Million DKK	0.0%
2019 Q1	10.65 Million DKK	90.59%
2019 FY	41.84 Million DKK	129.73%
2019 Q3	10.26 Million DKK	-3.71%
2018 Q4	5.59 Million DKK	0.0%
2018 Q2	3.51 Million DKK	0.0%
2018 FY	18.21 Million DKK	143.32%
2018 Q1	3.51 Million DKK	27.86%
2018 Q3	5.59 Million DKK	59.1%
2017 Q3	2.74 Million DKK	176.56%
2017 FY	7.48 Million DKK	-28.59%
2017 Q4	2.74 Million DKK	0.0%
2017 Q2	994 Thousand DKK	0.0%
2017 Q1	994 Thousand DKK	-39.5%
2016 FY	10.48 Million DKK	31.89%
2016 Q1	3.59 Million DKK	50.34%
2016 Q2	3.59 Million DKK	0.0%
2016 Q4	1.64 Million DKK	0.0%
2016 Q3	1.64 Million DKK	-54.34%
2015 Q4	2.39 Million DKK	0.0%
2015 FY	7.94 Million DKK	591.13%
2015 Q2	1.58 Million DKK	0.0%
2015 Q1	1.58 Million DKK	2550.39%
2015 Q3	2.39 Million DKK	51.44%
2014 Q1	639.5 Thousand DKK	313.17%
2014 Q3	-64.5 Thousand DKK	-110.09%
2014 Q4	-64.5 Thousand DKK	0.0%
2014 FY	1.15 Million DKK	232.37%
2014 Q2	639.5 Thousand DKK	0.0%
2013 Q2	473 Thousand DKK	0.0%
2013 Q4	-300 Thousand DKK	0.0%
2013 Q3	-300 Thousand DKK	-163.42%
2013 Q1	473 Thousand DKK	119.17%
2013 FY	346 Thousand DKK	103.51%
2012 Q3	-2.46 Million DKK	-9237.04%
2012 Q4	-2.46 Million DKK	0.0%
2012 FY	-9.86 Million DKK	-9237.04%
2012 Q2	27 Thousand DKK	0.0%
2012 Q1	27 Thousand DKK	0.0%
2011 Q1	-921.75 Thousand DKK	0.0%
2011 Q4	27 Thousand DKK	0.0%
2011 Q3	27 Thousand DKK	102.93%
2011 FY	108 Thousand DKK	102.93%
2011 Q2	-921.75 Thousand DKK	0.0%
2010 Q3	-921.75 Thousand DKK	-180.19%
2010 Q2	1.14 Million DKK	0.0%
2010 Q4	-921.75 Thousand DKK	0.0%
2010 Q1	1.14 Million DKK	0.0%
2010 FY	-3.68 Million DKK	-180.19%
2009 Q4	1.14 Million DKK	0.0%
2009 Q2	3.3 Million DKK	0.0%
2009 Q1	3.3 Million DKK	0.0%
2009 FY	4.59 Million DKK	-65.25%
2009 Q3	1.14 Million DKK	-65.25%
2008 FY	13.23 Million DKK	1469.4%
2008 Q4	3.3 Million DKK	0.0%
2008 Q3	3.3 Million DKK	824.53%
2008 Q1	357.75 Thousand DKK	0.0%
2008 Q2	357.75 Thousand DKK	0.0%
2007 Q4	357.75 Thousand DKK	0.0%
2007 Q3	357.75 Thousand DKK	-65.05%
2007 Q2	1.02 Million DKK	0.0%
2007 FY	843 Thousand DKK	-79.41%
2007 Q1	1.02 Million DKK	0.0%
2006 Q4	1.02 Million DKK	0.0%
2006 Q3	1.02 Million DKK	273.84%
2006 FY	4.09 Million DKK	273.84%
2006 Q1	-588.75 Thousand DKK	0.0%
2006 Q2	-588.75 Thousand DKK	0.0%
2005 FY	-2.35 Million DKK	76.49%
2005 Q3	-588.75 Thousand DKK	76.53%
2005 Q1	-2.5 Million DKK	0.0%
2005 Q2	-2.5 Million DKK	0.0%
2005 Q4	-588.75 Thousand DKK	0.0%
2004 Q4	-2.5 Million DKK	0.0%
2004 Q3	-2.5 Million DKK	0.0%
2004 FY	-10.01 Million DKK	0.0%

Peer Net Income Comparison of ChemoMetec A/S

Name	Net Income	Net Income Difference
Ambu A/S	235 Million DKK	42.007%
Demant A/S	1.79 Billion DKK	92.408%
GN Store Nord A/S	228 Million DKK	40.226%
Scandinavian Medical Solutions A/S	12.22 Million DKK	-1014.86%
ViroGates A/S	-12.09 Million DKK	1226.687%

Global Stocks Search

ChemoMetec A/S (CHEMM.CO)

Net Income Summary of ChemoMetec A/S

Annual Net Income Chart of ChemoMetec A/S (2024 - 2004)

Historical Annual Net Income of ChemoMetec A/S (2024 - 2004)

Peer Net Income Comparison of ChemoMetec A/S